{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T11:11:01Z","timestamp":1763809861305,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00204-018-2189-9","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T10:40:32Z","timestamp":1521456032000},"page":"1877-1891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Induction of hemangiosarcoma in mice after chronic treatment with S1P-modulator siponimod and its lack of relevance to rat and human"],"prefix":"10.1007","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7033-2033","authenticated-orcid":false,"given":"Francois","family":"Pognan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Andreas","family":"Mahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Papoutsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ledieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Raccuglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diethilde","family":"Theil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah B.","family":"Voytek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Kubek-Luck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Claudio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Cordier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabelle","family":"Heier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Kolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah-Dine","family":"Chibout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Page","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Trendelenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,19]]},"reference":[{"issue":"8","key":"2189_CR1","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1194\/jlr.R046300","volume":"55","author":"VA Blaho","year":"2014","unstructured":"Blaho VA, Hla T (2014) An update on the biology of sphingosine 1-phosphate receptors. J Lipid Res 55(8):1596\u20131608. https:\/\/doi.org\/10.1194\/jlr.R046300","journal-title":"J Lipid Res"},{"issue":"1","key":"2189_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","volume":"137","author":"O Braissant","year":"1996","unstructured":"Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137(1):354\u2013366. https:\/\/doi.org\/10.1210\/En.137.1.354","journal-title":"Endocrinology"},{"issue":"7070","key":"2189_CR3","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438(7070):932\u2013936. https:\/\/doi.org\/10.1038\/nature04478","journal-title":"Nature"},{"issue":"7347","key":"2189_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298\u2013307. https:\/\/doi.org\/10.1038\/nature10144","journal-title":"Nature"},{"issue":"19","key":"2189_CR5","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/ajmg.a.31333","volume":"140","author":"MM Cohen Jr","year":"2006","unstructured":"Cohen MM Jr (2006) Vascular update: morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet A 140(19):2013\u20132038. https:\/\/doi.org\/10.1002\/ajmg.a.31333","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2189_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/toxsci\/kfp131","volume":"111","author":"SM Cohen","year":"2009","unstructured":"Cohen SM, Storer RD, Criswell KA et al (2009) Hemangiosarcoma in rodents: mode-of-action evaluation and human relevance. Toxicol Sci 111(1):4\u201318. https:\/\/doi.org\/10.1093\/toxsci\/kfp131","journal-title":"Toxicol Sci"},{"issue":"1","key":"2189_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/toxsci\/kfs149","volume":"128","author":"KA Criswell","year":"2012","unstructured":"Criswell KA, Cook JC, Wojcinski Z et al (2012) Mode of action associated with development of hemangiosarcoma in mice given pregabalin and assessment of human relevance. Toxicol Sci 128(1):57\u201371. https:\/\/doi.org\/10.1093\/toxsci\/kfs149","journal-title":"Toxicol Sci"},{"key":"2189_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/B978-0-12-394274-6.00005-4","volume":"117","author":"O Cuvillier","year":"2013","unstructured":"Cuvillier O, Ader I, Bouquerel P, Brizuela L, Gstalder C, Malavaud B (2013) Hypoxia, therapeutic resistance, and sphingosine 1-phosphate. Adv Cancer Res 117:117\u2013141. https:\/\/doi.org\/10.1016\/B978-0-12-394274-6.00005-4","journal-title":"Adv Cancer Res"},{"issue":"1","key":"2189_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3858\/emm.2012.44.1.025","volume":"44","author":"S Falco De","year":"2012","unstructured":"De Falco S (2012) The discovery of placenta growth factor and its biological activity. Exp Mol Med 44(1):1\u20139. https:\/\/doi.org\/10.3858\/emm.2012.44.1.025","journal-title":"Exp Mol Med"},{"issue":"2","key":"2189_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/taap.1999.8763","volume":"160","author":"SK Duddy","year":"1999","unstructured":"Duddy SK, Gorospe SM, Bleavins MR, de la Iglesia FA (1999) Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies. Toxicol Appl Pharmacol 160(2):133\u2013140. https:\/\/doi.org\/10.1006\/taap.1999.8763","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"2189_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1095\/biolreprod.109.081604","volume":"82","author":"KA Dunlap","year":"2010","unstructured":"Dunlap KA, Kwak HI, Burghardt RC et al (2010) The sphingosine 1-phosphate (S1P) signaling pathway is regulated during pregnancy in sheep. Biol Reprod 82(5):876\u2013887. https:\/\/doi.org\/10.1095\/biolreprod.109.081604","journal-title":"Biol Reprod"},{"issue":"1","key":"2189_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40264-012-0006-6","volume":"36","author":"R Fuzier","year":"2013","unstructured":"Fuzier R, Serres I, Guitton E, Lapeyre-Mestre M, Montastruc JL, Pharmacovigilance FN (2013) Adverse drug reactions to gabapentin and pregabalin a review of the French pharmacovigilance database. Drug Saf 36(1):55\u201362. https:\/\/doi.org\/10.1007\/s40264-012-0006-6","journal-title":"Drug Saf"},{"issue":"7","key":"2189_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nchembio.392","volume":"6","author":"H Fyrst","year":"2010","unstructured":"Fyrst H, Saba JD (2010) An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol 6(7):489\u2013497. https:\/\/doi.org\/10.1038\/nchembio.392","journal-title":"Nat Chem Biol"},{"issue":"7","key":"2189_CR14","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/01.ATV.0000073832.49290.B5","volume":"23","author":"M Hristov","year":"2003","unstructured":"Hristov M, Erl W, Weber PC (2003) Endothelial progenitor cells\u2014mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23(7):1185\u20131189. https:\/\/doi.org\/10.1161\/01.Atv.0000073832.49290.B5","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2189_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.taap.2009.02.028","volume":"237","author":"S Kakiuchi-Kiyota","year":"2009","unstructured":"Kakiuchi-Kiyota S, Vetro JA, Suzuki S et al (2009) Effects of the PPARgamma agonist troglitazone on endothelial cells in vivo and in vitro: differences between human and mouse. Toxicol Appl Pharmacol 237(1):83\u201390. https:\/\/doi.org\/10.1016\/j.taap.2009.02.028","journal-title":"Toxicol Appl Pharmacol"},{"key":"2189_CR16","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1177\/1352458515616701","volume":"22","author":"L Kappos","year":"2016","unstructured":"Kappos L, Bar-Or A, Cree B et al (2016) Efficacy and safety of siponimod in secondary progressive multiple sclerosis\u2014results of the placebo controlled, double-blind, phase III EXPAND study. Mult Scler J 22:828\u2013829","journal-title":"Mult Scler J"},{"key":"2189_CR17","doi-asserted-by":"crossref","unstructured":"Kappos L, Bar-Or A, Cree B et al (2018) Siponimod versus placebo in secondary progressive multiple sclerosis: a double-blind randomised, phase 3 study. The Lancet (In press)","DOI":"10.1016\/S0140-6736(18)30475-6"},{"issue":"1","key":"2189_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jdermsci.2007.06.002","volume":"48","author":"T Kawanabe","year":"2007","unstructured":"Kawanabe T, Kawakami T, Yatomi Y, Shimada S, Soma Y (2007) Sphingosine 1-phosphate accelerates wound healing in diabetic mice. J Dermatol Sci 48(1):53\u201360. https:\/\/doi.org\/10.1016\/j.jdermsci.2007.06.002","journal-title":"J Dermatol Sci"},{"issue":"2","key":"2189_CR19","first-page":"151","volume":"79","author":"A Khaliq","year":"1999","unstructured":"Khaliq A, Dunk C, Jiang J et al (1999) Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for \u201cplacental hyperoxia\u201d in intrauterine growth restriction. Lab Investig J Tech Methods Pathol 79(2):151\u2013170","journal-title":"Lab Investig J Tech Methods Pathol"},{"issue":"9","key":"2189_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd4099","volume":"12","author":"GT Kunkel","year":"2013","unstructured":"Kunkel GT, Maceyka M, Milstien S, Spiegel S (2013) Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov 12(9):688\u2013702. https:\/\/doi.org\/10.1038\/nrd4099","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2189_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/toxsci\/kfp213","volume":"113","author":"D Laifenfeld","year":"2010","unstructured":"Laifenfeld D, Gilchrist A, Drubin D et al (2010) The role of hypoxia in 2-butoxyethanol-induced hemangiosarcoma. Toxicol Sci 113(1):254\u2013266. https:\/\/doi.org\/10.1093\/toxsci\/kfp213","journal-title":"Toxicol Sci"},{"issue":"3","key":"2189_CR22","doi-asserted-by":"publisher","first-page":"C612","DOI":"10.1152\/ajpcell.2000.278.3.C612","volume":"278","author":"H Lee","year":"2000","unstructured":"Lee H, Goetzl EJ, An S (2000) Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol Cell Physiol 278(3):C612\u2013C618","journal-title":"Am J Physiol Cell Physiol"},{"issue":"10","key":"2189_CR23","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMoa055352","volume":"355","author":"RJ Levine","year":"2006","unstructured":"Levine RJ, Lam C, Qian C et al (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355(10):992\u20131005. https:\/\/doi.org\/10.1056\/NEJMoa055352","journal-title":"N Engl J Med"},{"issue":"2","key":"2189_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/08977199309046934","volume":"8","author":"D Maglione","year":"1993","unstructured":"Maglione D, Guerriero V, Rambaldi M, Russo G, Persico MG (1993) Translation of the placenta growth-factor messenger-Rna is severely affected by a small open reading frame localized in the 5\u2032 untranslated region. Growth Factors 8(2):141\u2013152. https:\/\/doi.org\/10.3109\/08977199309046934","journal-title":"Growth Factors"},{"issue":"4","key":"2189_CR25","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1074\/jbc.M112.427344","volume":"288","author":"K Mendelson","year":"2013","unstructured":"Mendelson K, Zygmunt T, Torres-Vazquez J, Evans T, Hla T (2013) Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning. J Biol Chem 288(4):2143\u20132156. https:\/\/doi.org\/10.1074\/jbc.M112.427344","journal-title":"J Biol Chem"},{"issue":"Pt 12","key":"2189_CR26","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1242\/jcs.115.12.2559","volume":"115","author":"T Odorisio","year":"2002","unstructured":"Odorisio T, Schietroma C, Zaccaria ML et al (2002) Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci 115(Pt 12):2559\u20132567","journal-title":"J Cell Sci"},{"issue":"7","key":"2189_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1080\/01926230701748081","volume":"35","author":"T Ohnishi","year":"2007","unstructured":"Ohnishi T, Arnold LL, Clark NM, Wisecarver JL, Cohen SM (2007) Comparison of endothelial cell proliferation in normal liver and adipose tissue in B6C3F1 mice, F344 rats, and humans. Toxicol Pathol 35(7):904\u2013909. https:\/\/doi.org\/10.1080\/01926230701748081","journal-title":"Toxicol Pathol"},{"issue":"3","key":"2189_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1021\/ml300396r","volume":"4","author":"S Pan","year":"2013","unstructured":"Pan S, Gray NS, Gao W et al (2013) Discovery of BAF312 (Siponimod), a potent and selective S1P receptor modulator. ACS Med Chem Lett 4(3):333\u2013337. https:\/\/doi.org\/10.1021\/ml300396r","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"2189_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/toxsci\/kfs146","volume":"128","author":"D Pegg","year":"2012","unstructured":"Pegg D, Bleavins M, Herman J et al (2012) Hemangiosarcoma in mice administered pregabalin: analysis of genotoxicity, tumor incidence, and tumor genetics. Toxicol Sci 128(1):9\u201321. https:\/\/doi.org\/10.1093\/toxsci\/kfs146","journal-title":"Toxicol Sci"},{"issue":"6","key":"2189_CR30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S1074-7613(00)80068-0","volume":"10","author":"O Petrenko","year":"1999","unstructured":"Petrenko O, Beavis A, Klaine M, Kittappa R, Godin I, Lemischka IR (1999) The molecular characterization of the fetal stem cell marker AA4. Immunity 10(6):691\u2013700","journal-title":"Immunity"},{"issue":"6","key":"2189_CR31","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","volume":"146","author":"M Potente","year":"2011","unstructured":"Potente M, Gerhardt H, Carmeliet P (2011) Basic and therapeutic aspects of angiogenesis. Cell 146(6):873\u2013887. https:\/\/doi.org\/10.1016\/j.cell.2011.08.039","journal-title":"Cell"},{"issue":"7","key":"2189_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc2875","volume":"10","author":"NJ Pyne","year":"2010","unstructured":"Pyne NJ, Pyne S (2010) Sphingosine 1-phosphate and cancer. Nat Rev Cancer 10(7):489\u2013503. https:\/\/doi.org\/10.1038\/nrc2875","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2189_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/cvr\/cvq045","volume":"86","author":"S Rey","year":"2010","unstructured":"Rey S, Semenza GL (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 86(2):236\u2013242. https:\/\/doi.org\/10.1093\/cvr\/cvq045","journal-title":"Cardiovasc Res"},{"key":"2189_CR34","doi-asserted-by":"publisher","first-page":"645678","DOI":"10.1155\/2012\/645678","volume":"2012","author":"GT Richter","year":"2012","unstructured":"Richter GT, Friedman AB (2012) Hemangiomas and vascular malformations: current theory and management. Int J Pediatr 2012:645678. https:\/\/doi.org\/10.1155\/2012\/645678","journal-title":"Int J Pediatr"},{"key":"2189_CR35","unstructured":"RITA (2016) RITA: registry of industrial toxicology animal-data: database for historical data of tumors and pre-neoplastic lesions. https:\/\/reni.item.fraunhofer.de\/reni\/public\/rita\/"},{"key":"2189_CR36","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1146\/annurev-biochem-062411-130916","volume":"82","author":"H Rosen","year":"2013","unstructured":"Rosen H, Stevens RC, Hanson M, Roberts E, Oldstone MB (2013) Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. Annu Rev Biochem 82:637\u2013662. https:\/\/doi.org\/10.1146\/annurev-biochem-062411-130916","journal-title":"Annu Rev Biochem"},{"issue":"10","key":"2189_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721\u2013732. https:\/\/doi.org\/10.1038\/nrc1187","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2189_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1095\/biolreprod.105.046714","volume":"74","author":"ME Skaznik-Wikiel","year":"2006","unstructured":"Skaznik-Wikiel ME, Kaneko-Tarui T, Kashiwagi A, Pru JK (2006) Sphingosine-1-phosphate receptor expression and signaling correlate with uterine prostaglandin-endoperoxide synthase 2 expression and angiogenesis during early pregnancy. Biol Reprod 74(3):569\u2013576. https:\/\/doi.org\/10.1095\/biolreprod.105.046714","journal-title":"Biol Reprod"},{"issue":"1","key":"2189_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/ilar\/ilx016","volume":"58","author":"DP Stiehl","year":"2017","unstructured":"Stiehl DP, Tritto E, Chibout SD, Cordier A, Moulin P (2017) The utility of gene expression profiling from tissue samples to support drug safety assessments. Ilar J 58(1):69\u201379. https:\/\/doi.org\/10.1093\/ilar\/ilx016","journal-title":"Ilar J"},{"issue":"9","key":"2189_CR40","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1194\/jlr.R046656","volume":"55","author":"K Takabe","year":"2014","unstructured":"Takabe K, Spiegel S (2014) Export of sphingosine-1-phosphate and cancer progression. J Lipid Res 55(9):1839\u20131846. https:\/\/doi.org\/10.1194\/jlr.R046656","journal-title":"J Lipid Res"},{"issue":"10","key":"2189_CR41","doi-asserted-by":"publisher","first-page":"298","DOI":"10.4331\/wjbc.v1.i10.298","volume":"1","author":"Y Takuwa","year":"2010","unstructured":"Takuwa Y, Du W, Qi X, Okamoto Y, Takuwa N, Yoshioka K (2010) Roles of sphingosine-1-phosphate signaling in angiogenesis. World J Biol Chem 1(10):298\u2013306. https:\/\/doi.org\/10.4331\/wjbc.v1.i10.298","journal-title":"World J Biol Chem"},{"issue":"6","key":"2189_CR42","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","volume":"12","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha S, Toporsian M, Lam C et al (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12(6):642\u2013649. https:\/\/doi.org\/10.1038\/nm1429","journal-title":"Nat Med"},{"issue":"12","key":"2189_CR43","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1182\/blood.V90.12.5002","volume":"90","author":"AH Yin","year":"1997","unstructured":"Yin AH, Miraglia S, Zanjani ED et al (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90(12):5002\u20135012","journal-title":"Blood"},{"issue":"4","key":"2189_CR44","first-page":"517","volume":"76","author":"M Ziche","year":"1997","unstructured":"Ziche M, Maglione D, Ribatti D et al (1997) Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Investig: J Tech Methods Pathol 76(4):517\u2013531","journal-title":"Lab Investig: J Tech Methods Pathol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-018-2189-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-018-2189-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-018-2189-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T11:39:20Z","timestamp":1660649960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-018-2189-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,19]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["2189"],"URL":"https:\/\/doi.org\/10.1007\/s00204-018-2189-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"type":"print","value":"0340-5761"},{"type":"electronic","value":"1432-0738"}],"subject":[],"published":{"date-parts":[[2018,3,19]]},"assertion":[{"value":"16 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors were employed and salaried by Novartis Pharma AG.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}